Trial Profile
Muscle Cell Mediated Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery: An Investigation of Cook MyoSite Autologous Muscle Derived Cells
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 28 Oct 2021
Price :
$35
*
At a glance
- Drugs Iltamiocel (Primary)
- Indications Stress incontinence
- Focus Adverse reactions; Therapeutic Use
- Sponsors Cook MyoSite
- 29 Aug 2019 Status changed from active, no longer recruiting to completed.
- 02 Jul 2019 Planned End Date changed from 1 Jun 2019 to 1 Jul 2019.
- 02 Jul 2019 Planned primary completion date changed from 1 Jun 2019 to 1 Jul 2019.